Internal Medicine, Hematology & Oncology · Chambersburg, PA
NPI
1700878683
Since 2005
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
22 St Paul Dr Ste 100
Chambersburg, PA, 17201
Phone (717) 217-6020
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.5M
188,356 services
Medicare patients, 2024
533
Average age 75
Drug cost, 2024
$5.2M
1,349 prescriptions
Company payments, 2023
$83.82
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kevin J Lorentsen was code Q0138 (injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)), 21,420 times for 28 patients. In total Kevin J Lorentsen billed 188,356 services in 113 codes, and Medicare paid $2.5M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-03-14.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 21,420 | 28 | $0.27 | $5,786 |
| J9271 Injection, pembrolizumab, 1 mg | Office | 12,400 | 14 | $44.48 | $551K |
| J1756 Injection, iron sucrose, 1 mg | Office | 6,600 | 12 | $0.18 | $1,179 |
| J0897 Injection, denosumab, 1 mg | Office | 6,120 | 29 | $20.53 | $126K |
| Q5106 Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | Office | 4,790 | 16 | $5.80 | $28K |
| J9267 Injection, paclitaxel, 1 mg | Office | 4,095 | 13 | $0.08 | $332 |
| J1453 Injection, fosaprepitant, 1 mg | Office | 2,400 | 12 | $0.11 | $265 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,858 | 52 | $0.09 | $168 |
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 940 | 24 | $0.07 | $69.85 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 510 | 26 | $0.70 | $357 |
| 99214 Office E&M - Established | Office | 493 | 187 | $94.58 | $47K |
| 96372 Injection Administration | Office | 422 | 88 | $10.64 | $4,489 |
| 99213 Office E&M - Established | Office | 420 | 266 | $66.01 | $28K |
| 96375 Injection Administration | Office | 296 | 60 | $11.27 | $3,337 |
| 96413 Chemotherapy Administration | Office | 282 | 79 | $94.06 | $27K |
By year: 2022 $2.0M for 153,274 services; 2023 $2.0M for 108,412 services; 2024 $2.5M for 188,356 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kevin J Lorentsen prescribed most often to Medicare patients was Anastrozole, with 126 prescriptions and refills. In total Kevin J Lorentsen wrote 1,349 Medicare prescriptions that cost $5.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 126 | 346 | 39 | $3,501 |
| Letrozole Generic | 117 | 283 | 38 | $2,522 |
| Hydroxyurea Generic | 78 | 192 | 21 | $2,110 |
| Ondansetron Hcl Generic | 76 | 78 | 49 | $1,113 |
| Eliquis Apixaban | 67 | 143 | 15 | $77K |
| Potassium Chloride Generic | 58 | 96 | 18 | $854 |
| Dexamethasone Generic | 53 | 87 | 18 | $1,388 |
| Acyclovir Generic | 53 | 95 | 11 | $1,361 |
| Brukinsa Zanubrutinib | 47 | 47 | Under 11 | $698K |
| Prednisone Generic | 43 | 72 | 15 | $264 |
| Pomalyst Pomalidomide | 41 | 41 | Under 11 | $931K |
| Warfarin Sodium Generic | 39 | 87 | Under 11 | $502 |
| Olanzapine Generic | 35 | 35 | 14 | $161 |
| Lenalidomide Generic | 34 | 34 | Under 11 | $490K |
| Imatinib Mesylate Generic | 29 | 29 | Under 11 | $75K |
Brand drugs: 376 claims; generic drugs: 973 claims.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid Kevin J Lorentsen $83.82 ($83.82 in general payments such as food, travel and fees) from 1 company. The largest payer was Sobi, Inc with $83.82.
| Company | Payments | Amount |
|---|---|---|
| Sobi, Inc SOBI.ST | 1 | $83.82 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.